IFF expands the launch of industry-leading poultry solutions in the EU

IFF announced EU-wide regulatory approval for two of its groundbreaking feed solutions for poultry. Axtra XAP – a multi-enzyme blend and Syncra AVI – an enzyme-probiotic complex from Danisco Animal Nutrition & Health, IFF's Health & Biosciences business unit, are formulated to meet the challenges of modern poultry production and deliver measurable performance improvements.

"Obtaining full EU authorization empowers us to unleash the remarkable potential of these two exceptional in-feed products to poultry producers across the region," said Jose Luis Ecija Roux, marketing director EMEA, Danisco Animal Nutrition & Health. "Axtra XAP and Syncra AVI have demonstrated their pivotal role in advanced feed strategies, and we look forward to helping our customers in maximizing this unprecedented opportunity."

Axtra XAP - fuels efficiency and reduces costs

Axtra XAP, a high-performance xylanase, amylase and protease enzyme combination, increases energy efficiency and improves bird performance in both corn-based and mixed-grain diets. Through optimized nutrient availability, this unique feed solution enables greater flexibility in dietary formulations, significantly reduces feed costs and improving profitability1. Additionally, Axtra XAP allows producers to adapt their operations to meet consumer demands and industry trends, including free-range production and the use of all-vegetable dietary ingredients.

Syncra AVI, a gut health revolution

Syncra AVI combines two proven technologies – enzymes and probiotics – known to optimize gut health and maximize performance in poultry production. The synergistic combination of enzymes and probiotics in Syncra AVI helps to create a favorable nutribiotic state that supports flock health, wellness, and productivity. Nutribiosis is the interplay between nutrition, microbiome, gut and immune function where they interact in the host.

The EU is the latest region to launch Axtra XAP and Syncra AVI. Both solutions are currently available in major markets around the world including North America, South Africa and Asia Pacific.

1 Internal experimental data